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Abstract 
Human tissue is bombarded by a huge range of chemicals. Our lungs are inhaling pollution from both 
stationary and mobile sources as well as inhaled nanoparticles (NPs) and therapeutic products designed 
to provide new and innovative medical solutions. Our challenge is to identify what exposures are putting 
us at risk and balance the risk against benefits that we may receive from these chemicals and new 
products. Advances inin vitrocell culture technology may provide some of the answers. Regulatory 
toxicologists and health and safety professionals need rapid and reliable information on hazard profiles of 
chemicals to be able to assess the risk and manage potential exposures to harmful materials. in vivo 
studies require a large number of expensive, time consuming and in some cases non humane tests in 
animal species. Recent innovations in human cell culture exposure and test systems has allowed the 
development ofin vitro assay systems that are predictive, representative and suitable for toxicity 
screening of a diverse range of chemicals including airborne materials and nanomaterials (NMs). 
Innovative in vitro exposure techniques that have been developed to provide direct exposure of human 
lung cells to inhaled materials and nanomaterials will be discussed. Further development and validation 
of such test systems are crucial for evidence based safety evaluation and risk assessment of inhaled 
materials, nanomaterials and therapeutic products. 
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Introduction 
Human tissue is bombarded by a huge range of chemicals. Our 
lungs are inhaling pollution from both stationary and mobile sources as 
well as inhaled nanoparticles (NPs) and therapeutic products designed 
to provide new and innovative medical solutions. Our challenge is 
to identify what exposures are putting us at risk and balance the risk 
against benefits that we may receive from these chemicals and new 
products [1-4]. Advances in in vitro cell culture technology may provide 
some of the answers.
Regulatory toxicologists and health and safety professionals need 
rapid and reliable information on hazard profiles of chemicals to 
be able to assess the risk and manage potential exposures to harmful 
materials. In vivo studies require a large number of expensive, time 
consuming and in some cases non humane tests in animal species [3]. 
Recent innovations in human cell culture exposure and test systems has 
allowed the development of in vitro assay systems that are predictive, 
representative and suitable for toxicity screening of a diverse range 
of chemicals including airborne materials and nanomaterials (NMs) 
[1,3,5]. Innovative in vitro exposure techniques that have been 
developed to provide direct exposure of human lung cells to inhaled 
materials and nanomaterials will be discussed. Further development 
and validation of such test systems are crucial for evidence based safety 
evaluation and risk assessment of inhaled materials, nanomaterials and 
therapeutic products. 
Exposure to Inhaled Materials
Inhalation is the most common route of exposure for airborne 
materials and nanomaterials to enter our body either unintentionally 
or deliberately. The range of airborne materials may include individual 
airborne contaminants, diesel exhaust and complex atmospheres, 
aerosols of nanoparticles and nanomaterials and inhaled therapeutics.
Individual airborne contaminants
Exposure to airborne contaminants is a major contributor to 
human health problems. Inhalation of gases, vapours, and aerosols can 
cause a wide range of adverse health effects ranging from mild irritation 
to systemic diseases [2,4,6-11]. It is possible through conventional 
chemical analysis techniques to sample and analyse contaminated air 
but, such data provides neither direct measures of toxicity nor the precise 
mechanisms that derive toxic effects. Inhalation is considered the most 
important means by which humans are exposed to airborne chemicals, 
however, available in vivo toxicity data is mostly from oral and dermal 
exposures rather than inhalation exposure. This demonstrates the 
importance of exploring new alternative approaches to provide toxicity 
information on various ranges of airborne materials. Developing in 
vitro techniques that are comparable to in vivo environments during 
inhalation exposures are crucial to provide evidence for precise 
mechanisms by which inhaled materials induce toxic effects. 
Diesel exhaust and complex atmospheres
In real world situations such as occupational environments or 
polluted cities, people are exposed to a variety of airborne chemicals 
simultaneously. For example, exposures to industrial solvents and 
volatile organic compounds usually involve a mixture of chemicals 
rather than a single compound [4]. Smoke inhalation from tobacco 
smoke [12] or fire combustion products [13] is another example of 
human exposure to multiple airborne toxicants consisting of both 
gaseous and particulate fractions. Motor vehicles such as diesel powered 
engines are main contributors to air pollution in urban environments 
and industrial settings such as mine industry [14]. Diesel exhaust 
emission is a major health concern due to its complex nature of gases, 
particulates and nanoparticles and mixture of these [15]. Often the toxic 
effects of multiple exposures assumed to be additive but, other possible 
and more severe synergistic or potentiation interactions of chemicals or 
gaseous and particulate components of complex atmospheres need to 
be considered [4]. Considering the multitude of airborne contaminants 
that usually occur in real life and workplace environments, development 
of appropriate toxicity test methods would be vital for comprehensive 
toxicity assessment of complex atmospheres, identifying the main 
toxicants causing adverse effects and understanding the potential 
mechanisms responsible for toxic actions. 
Inhaled nanoparticles and nanomaterials
With the rapid development and commercialisation of 
nanotechnology based products the pattern of human exposure to 
particulates is about to change enormously. While nanoparticles and 
nanomaterials may enter into human body via inhalation, dermal, oral 
and injection either unintentionally or deliberately, inhalation exposure 
to nanoscale (1-100 nm) particles has become an emerging health 
concern. Research suggests that NPs may react very differently from the 
parent materials due to their unique physicochemical characteristics 
such as small size distribution, large surface area to mass ratio and surface 
characteristics [1,5,16,17]. As research and business both continue to 
invest increasingly on nanotech products, more research is also needed 
to assess the potential adverse effects of nanoparticles. Safety assessment 
should be considered as an integral part of nanomaterial design and 
manufacture to ensure the health and safety of workers, consumers as 
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well as the environment. Currently, several research projects related 
to nanotoxicology and nanosafety are being conducted worldwide 
by international organisations such as the OECD (The Organisation 
for Economic Cooperation and Development), WHO (World Health 
Organisation) and US NIOSH (US National Institute of Occupational 
Safety and Health), that can facilitate international collaboration to 
understand potential risks of NPs and to protect human health from 
exposure to nanomaterials.
Inhaled therapeutics 
Many inhaled therapeutics are delivered to the lung to elicit a 
local remedial effect, usually for asthma, COPD (chronic obstructive 
pulmonary disease) and other lung disorders [18]. Recently, anti-
inflammatory and anti-coagulant inhalable dry powder products such 
as heparin and pentoxifylline have been introduced as an alternative 
administration for the treatment of smoke inhalation [19]. As inhalation 
facilitates the rapid access of materials into the blood stream it can 
also provide an excellent route of administration for systemic delivery 
of therapeutics such as protein and peptide containing products. 
However, when chronic treatment is required such as systemic delivery 
of insulin, human growth hormone and other proteins, extensive 
toxicology studies of inhaled therapeutics would be essential.
Inhalation technology is an important issue in both preclinical 
and clinical studies of respiratory products because of the technical 
requirements of aerosol generation and delivery devices [20]. For 
toxicity evaluation of inhaled therapeutics, both local and systemic 
responses must be assessed. Local effects can be assessed by specific 
inhalation toxicology methods and toxicokinetics models can be 
implemented to predict systemic effects. Therefore, for comparisons 
between pre-clinical and clinical exposures in relation to toxic end 
points and prediction of clinical dose, pharmacokinetics information 
would be very informative [21].
In Vivo Models of Toxicity Assessment
Traditionally, inhalation toxicology data have been generated 
using animal models. Inhalation toxicity tests are carried out on test 
animals to identify the median lethal concentration (LC50) of airborne 
chemicals causing death as a toxic end point in 50% of exposed 
animals. Later maximum tolerable concentration (LC0) has been 
introduced as a more ethically acceptable endpoint. The OECD has 
established a number of Test Guidelines (TGs) for acute, repeated dose 
and sub-chronic inhalation toxicity testing (e.g. TG 403, 412, 413) [22]. 
However, there are some difficulties unique to inhalation studies that 
have been identified [23]. 
To conduct adequate toxicology studies, it is important to quantify 
the delivered dose. Estimating the dose received by animals is one of 
the challenging issues of inhalation toxicology as several factors may 
influence the actual dose such as airborne concentration, duration 
of exposure and respiratory characteristics of the test animal, which 
modulate the deposition/absorption pattern of the airborne material. 
In vivo inhalation assessments include the determination of regional 
localisation and quantification of the deposited material in specific 
anatomical sub-regions of the respiratory tract, followed by macroscopic 
and microscopic tissue evaluation, target organ toxicity and estimation 
of the clearance rate [18]. Therefore, the selection of animal species for 
inhalation studies is a key factor, that may influence the outcome of in 
vivo studies and hence the extrapolated human adverse health effects. 
Generation and characterisation of high volume test atmospheres 
and reproducible exposure conditions are more complicated and 
expensive compared to oral and dermal exposures. This process 
requires specialised equipment and techniques to generate, maintain 
and monitor test atmospheres. Inhalation exposure systems involve 
several efficient and precise sub-systems, including a conditioned air 
supply system, an appropriate gas or aerosol generator for the test 
material, a dilution and delivery system, flow monitoring system/s, 
exposure chamber, real-time monitoring or sampling and analytical 
system, and an exhaust/filter or scrubbing system [24].
In Vitro Models of Toxicity Assessment
In vitro toxicology test methods for toxicity testing of inhaled 
materials have been developed using animal or human based cellular 
systems and relevant biological endpoints. In vitro test methods have 
the potential to serve as the primary choice for toxicity screening of 
inhaled materials and nanomaterials as they are convenient, cost and 
time efficient and involve no ethical issues. Typical in vitro bioassays 
include cell viability (e.g. trypan blue dye exclusion), cell metabolism 
such as tetrazolium salts (MTT, MTS and XTT) and membrane leakage 
such as loss of lactate dehydrogenase (LDH) assays [5]. Biological 
responses and toxicity endpoints resulted from nanomaterial exposure 
that can be related to their physicochemical characteristics have been 
reviewed [1,4,18]. Damage to cell walls and plasma membrane, ROS 
(reactive oxygen species) generation and oxidative stress are among 
common mechanisms responsible for toxicity of NMs.  
To overcome the challenges and limitations of in vivo inhalation 
studies, practical in vitro methods for toxicity testing of inhaled 
materials have been developed using human airway cells, lung cells 
or tissues and implementation of target specific end-points [25,26]. 
Although in vitro lung models do not represent the complexity of 
the whole respiratory system, many questions related to inhalation 
toxicology can be answered using physiologically relevant human lung 
cells and tissue models replicating the native cellular structure and tissue 
architecture of the respiratory system [5,24]. Models of the human lung 
are available for all regions of the respiratory tract, including nasal, 
trachea bronchial and pulmonary region. However, lung cell culture 
models should be selected in a way to represent the most important 
features of their corresponding region in the respiratory tract.  
Considering the complex nature of the architecture of the lung, 
various in vitro models can be implemented representing the proximal 
and distal regions of the respiratory tract. Cells and cell lines of human 
airway (e.g. calu-3 human cell line) and alveolar epithelium (e.g. A549 
human epithelial type II cell lines) have been frequently used in toxicity 
testing of inhaled materials and nanomaterials [27]. In addition, 
alveolar macrophages are among the first cellular systems responding 
to inhaled materials and can be obtained as primary cultures of 
pulmonary lavage or cell lines. Insoluble or low water soluble gases 
and vapours as well as ultra-fine particles and nanoparticles have a 
potential to access deeply into the distal lung in which, the pulmonary 
epithelium is composed of two distinct cell types of alveolar type I 
(AE1) and alveolar type II (AE2) serving diverse essential functions 
in the alveolar region. The development of distal lung tissue models is 
challenging due to the multicellular nature and complex structure of 
the alveoli but, recently promising approaches toward construction of 
3D alveolar tissue models have been reported [27-30].
The development and implementation of engineered tissue 
equivalents of the lung need to be investigated further, similar to those 
models designed for other organs such as the skin [31]. Engineered 
cell culture scaffolds provide mechanical support for cells in the form 
of meshes, sponges and films consisting of a wide range of synthetic 
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materials or natural biomaterials [31]. Recently, a morphologically and 
functionally differentiated in vitro cellular model of the human airway 
epithelium (MucilAirTM, Epithelix) has been commercialised that can 
be maintained at the homeostatic state at least for one year [32].  
In vitro test systems using cultured cells can be controlled precisely 
providing more reproducible toxicity data than in vivo models but 
requires higher standardisation. The main technical challenge of in 
vitro testing of inhaled materials is to mimic inhalation exposure in 
cultured cells or tissues. Therefore, an optimal in vitro exposure system 
for studying the cellular responses to inhaled materials needs to meet 
several requirements [3,33-36]. Such requirements include:
• Continuous direct exposure of target cells to unmodified 
airborne materials with no intervening layer of media, 
• Providing a significant time course to study potential biological 
effects,
• Continual nourishment of cells during the exposure time, and
• Supporting other requirements of the cellular system such as 
appropriate levels of pH, humidity and temperature,
• Duplication of in vivo parameters without system-related 
toxicity, and
• Offering an uncomplicated exposure system with a reasonable 
cost. 
To address the basic requirement of gas phase exposure of airborne 
materials several exposure methods have been developed. Different 
features of such exposure techniques have been discussed in terms of 
their relevance, advantages and limitations [3,5,33,34]. These methods 
mainly include exposure of cells under submerged conditions, 
intermittent exposure procedures and more recently direct exposure 
techniques at the air–liquid interface (ALI). The latest will be discussed 
as the most relevant method that can fulfil the above mentioned 
requirements.
Direct exposure at the air-liquid interface
Over recent years, there has been a significant development and 
breakthrough in toxicity testing of airborne materials in vitro [3,5,34-42]. 
Human cells were cultured on commercially available porous membranes 
permeable to culture media (Figure 1). Cells grown on porous membranes 
accommodated in exposure chamber systems were adapted for dynamic 
delivery and direct exposure of human cells to airborne materials providing 
a very close contact between target cells and test atmospheres similar to in 
vivo condition. Dynamic delivery of test atmospheres and direct exposure 
of human cells to airborne chemicals under ALI conditions were achieved 
using specifically constructed exposure chambers such as the CULTEX 
system [40], or horizontal diffusion chamber (Harvard Apparatus Inc., 
USA) systems [36]. 
Cellular responses to individual airborne chemicals such as NO2, 
NH3, O3 and SO2 [36-38,41] and complex mixtures such as diesel 
exhaust [14,42,43], cigarette smoke [44] and fire combustion products 
[13] have been studied using human lung cells grown on porous 
membranes. The dynamic direct exposure technique at the air–liquid 
interface offers a continuous contact between unmodified airborne 
chemicals and target cells and technically simulates in vivo inhalation 
exposure as closely as possible. Mobile exposure systems that can be 
operated independently from the cell culture incubator utilising heat 
water circulation, heat block or a heat cartridge, offer an advantage for 
an on-site toxicity investigation of airborne contaminants and complex 
atmospheres [14]. 
A commercially available perfusion chamber system (MINUCELL) 
was modified to allow the homogeneous deposition of fine and 
ultrafine aerosols into the membrane surface for in vitro exposure 
purposes [45]. Uniform particle deposition and a well-defined dose 
were achieved through this experimental setup [46]. For dynamic 
direct exposure of target cells to nanoscale aerosols at the air-liquid 
interface the Karlsruhe exposure system (Vitrocell, Germany) was also 
used [47,48]. To determine the accurate dose reaching the target cells, 
the membrane insert was replaced by a quartz crystal microbalance 
inside the exposure chamber and exposed to nano-aerosols to predict 
the deposited mass per area unit. 
Technical improvements were also made to the CULTEX (Vitrocell, 
Germany) system utilising inlet tubes with a hyperboloid-shaped air 
distribution section made from Teflon or surface-treated stainless 
steel with up to 80% deposition efficiency for NPs [49]. Further, the 
radial flow system was designed for exposing of cells to micro and 
nanoscale particles using the computational fluid dynamics analysis 
to ensure reproducible and homogeneous deposition of particles 
[50]. More recently, a new computer-controlled air-liquid interface 
cultivation system was developed for generating 3D cultures of the 
airway epithelium [51]. In vitro exposure techniques that accomplish 
the essential requirements of cell culture systems for toxicity testing of 
inhaled materials are developing rapidly providing advanced tools for 
integrated toxicity assessment of diverse range of airborne materials 
and nanomaterials.
Conclusion and Perspective
Recent innovations in human cell culture and exposure techniques 
have allowed the development of in vitro assay systems that are 
predictive, representative and suitable for toxicity screening of a 
diverse range of chemicals including inhaled materials. Standardised 
 
Figure 1: Direct exposure of human cells at the air-liquid interface.
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in vitro test systems can be controlled precisely providing more reliable 
and reproducible toxicity data. An optimal in vitro exposure system 
for studying the cellular responses of inhaled materials needs to meet 
several technical requirements mainly the challenge of simulating 
inhalation exposure in cultured cells or tissues. 
To overcome the challenge, innovative in vitro exposure techniques 
at the air liquid interface have been developed using human cells 
cultured on porous membranes that offer new possibilities to test 
biological responses of inhaled materials under physiologically relevant 
conditions. Such in vitro assay systems are an important research tools 
for developing a toxicity data bank on human exposure to a range of 
inhaled materials, nanomaterials and therapeutic products in a rapid 
reliable manner that will give regulatory toxicologists and health and 
safety professional’s valuable evidence to assess the risk and manage 
potential exposures.
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